What is CDSCO and What Does It Regulate?

CDSCO is India's national regulator for medical devices, drugs and cosmetics. Any foreign medical device entering India must be registered with CDSCO before it can legally clear customs. Import without valid CDSCO registration results in detention, confiscation and criminal liability under the Drugs and Cosmetics Act, 1940.

What is CDSCO?

The Central Drugs Standard Control Organisation (CDSCO) is the national regulatory authority for drugs, medical devices, diagnostics and cosmetics in India that operates under the Ministry of Health and Family Welfare, Government of India headed by the Drugs Controller General of India (DCGI). The DCGI holds statutory authority over import approvals, clinical trial clearances, market authorisations and post-market surveillance for all regulated categories.

CDSCO derives its mandate from the Drugs and Cosmetics Act, 1940 that governs manufacture, import, distribution and sale of drugs and medical devices in India. Medical devices were brought formally within the regulatory framework by the Medical Devices Rules, 2017, which became operative on 1st January 2018 establishing a systematic classification regime and registration requirement applicable to a far wider range of products.

CDSCO operates through a central secretariat in New Delhi and a network of zonal offices across India. These zonal offices are located in Mumbai, Kolkata, Chennai, Ahmedabad, Hyderabad, and other cities. They conduct inspections, process applications and coordinate enforcement with state drug authorities. The SUGAM portal (cdscoonline.gov.in) is CDSCO's official digital interface for all registration and licence applications, including those filed by foreign manufacturers and Indian importers.

The scope of CDSCO regulation

All medical devices sold or imported in India, regardless of country of origin are subject to MDR 2017. The rules apply, whether the device is sold directly to institutions, distributed through trading channels or imported for personal clinical use. The European Conformitè Europëenne (CE) mark or FDA clearance granted by the United States Food and Drug Administration carries no legal weight in India and such device requires independent CDSCO registration before it enters Indian territory.

Implications for businesses

Foreign medical device manufacturers exporting to India must process CDSCO registration before the first shipment departs. The registration is product-specific and manufacturer-specific. A company that holds registration for one model does not automatically hold registration for a variant with a different intended use or technical specification. Registration lapses must be renewed before the renewal date, as customs authorities cross-check against CDSCO's live approved device list.

A Class C or Class D device requires 12 to 18 months to clear the CDSCO registration process and initiating the registration process after receiving a purchase order from an Indian buyer will violate deadlines.

Indian importers and distributors carry equal legal exposure. Under the Drugs and Cosmetics Act, 1940, the Indian importer is a named party in the import licence application and bears direct regulatory responsibility for the conformance of goods imported under that licence. An Indian distributor importing unregistered devices even in good faith and relying on assurances from a foreign supplier can face seizure of stock, suspension of import authorisations and prosecution.

How CDSCO compliance works

The CDSCO compliance process begins on the SUGAM portal (cdscoonline.gov.in), mandatory electronic gateway for all medical device registration applications. There is no paper-only route. Foreign manufacturers and Indian importers must both create accounts on SUGAM before any application can be filed.

For Class B medical devices, covering products such as hypodermic needles, blood pressure monitors, thermometers and hearing aids, the Indian importer applies for an import licence using Form MD-14. The application must include technical documentation, a certificate of free sale issued by the regulatory authority in the country of manufacture and details of the Authorised Indian Representative where required.

For Class C and Class D devices, covering orthopaedic implants, cardiac pacemakers, coronary stents, lung ventilators and similar high-risk products, the foreign manufacturer must register directly with CDSCO using Form MD-15. This registration requires appointment of an Authorised Indian Representative (AIR), a legal entity registered in India under the Companies Act or as an LLP, which accepts legal responsibility for the manufacturer's obligations under MDR 2017. The AIR cannot be an individual.

Class A devices, the lowest-risk category covering bandages, tongue depressors, wheelchairs, and stethoscopes require registration through a simplified process but the legal obligation remains. The device must appear on CDSCO's approved list before it can be imported.

Legality and risks

Section 13 of the Drugs and Cosmetics Act, 1940 prohibits the import of any drug or device in contravention of the Act's provisions. Violation thereof carries imprisonment for a term that may extend to three years, a fine or both. Directors and officers of the importing entity can be personally named in criminal proceedings.

At the port, customs authorities cross-check medical device shipments against CDSCO's published approved device list. Shipments without valid CDSCO registration are detained at the port. Detained goods accumulate demurrage and ground rent charges from the first day. Non-compliant goods face confiscation or re-exported or a specific exemption order is obtained from CDSCO.

A company that clears the port can still face enforcement action if the imported device generates adverse event reports or is found non-conforming in post-market checks conducted by CDSCO. Prior detention or prosecution amounts to heightened scrutiny on subsequent applications and at subsequent import events.

Word of counsel

Importers should begin with complete documentation, appoint a qualified AIR who understands CDSCO's technical expectations and budget realistic timelines and not plan an Indian market entry around a registration that has not yet been applied for.

Have a question about a specific product or regulation? Speak to an expert at accessindiaplatform.com